Latest filing published 07 Feb 2025 for 동구바이오제약.
이경옥 discloses dealings in 동구바이오제약 to DART (FSS). Over a trading history stretching from 26 February 2021 to 7 February 2025, the count stands at 14 filings.
The open-market record consists of 14 sales, with no purchase. The totals do not cover 14 filings with an undisclosed amount. Since January 2025: no purchases and 1 sale on the market.
The record was last updated on 7 February 2025 with an open-market sale in 동구바이오제약. Between a trade and the moment it shows up on DART (FSS), the median delay is 7 days. That lag is the time during which only the insider knows about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations